Vertex Pharmaceuticals Inc / Ma: Peers

The FY2024 (Dec) proxy of Vertex Pharmaceuticals Inc / Ma names 12 peer companies for pay. Among Vertex Pharmaceuticals Inc / Ma and these peers, CEO pay was 5th highest of 9 and total shareholder return was 5th highest of 9.

5th highest of 9in Vertex Pharmaceuticals Inc / Ma and its pay peers, FY2024 (Dec) by CEO pay:

$6.8M$29.2M

5th highest of 9in Vertex Pharmaceuticals Inc / Ma and its pay peers, FY2024 (Dec) by total shareholder return:

$52$627

Pay peer group, FY2024 (Dec) proxy

Eli Lilly & Co
Amgen
Biogen
Gilead Sciences
Bristol Myers Squibb
AbbVie
Incyte
Regeneron Pharmaceuticals
Alnylam PharmaceuticalsNot disclosedNot disclosed
BioMarin Pharmaceuticals, Inc.Not disclosedNot disclosed
Jazz Pharmaceuticals plcNot disclosedNot disclosed
ModernaNot disclosedNot disclosed
12 companies

Changes by year

FY2025 (Dec) proxy

  • RemovedSeagen Inc.pay peer groupsince 2022, except for the removal of Seagen Inc. in 2024 due to its acquisition by

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.